In gastric cancer, serum-derived IL-6 activates and induces MDSCs, which express arginase 1, via the PI3K-Akt signaling pathway, thereby suppressing cytotoxic T cell functionality [29]. This evidence concerns the gene ARG1 and gastric cancer.